Results
1
-
3
of
3
[DOI: 10.1021/jm901691y]
[DOI: 10.1021/jm0104062]
The novel suramin analogue NF864 selectively blocks P2X1 receptors in human platelets with potency in the low nanomolar range
,
Naunyn-Schmiedeberg's Archives of Pharmacology
[DOI: 10.1007/s00210-005-1085-z]